Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons

J Neurosci. 1999 Nov 15;19(22):9705-15. doi: 10.1523/JNEUROSCI.19-22-09705.1999.

Abstract

Opioid receptor agonists are known to alter the activity of membrane ionic conductances and receptor-activated channels in CNS neurons and, via these mechanisms, to modulate neuronal excitability and synaptic transmission. In neuronal-like cell lines opioids also have been reported to induce intracellular Ca(2+) signals and to alter Ca(2+) signals evoked by membrane depolarization; these effects on intracellular Ca(2+) may provide an additional mechanism through which opioids modulate neuronal activity. However, opioid effects on resting or stimulated intracellular Ca(2+) levels have not been demonstrated in native CNS neurons. Thus, we investigated opioid effects on intracellular Ca(2+) in cultured rat hippocampal neurons by using fura-2-based microscopic Ca(2+) imaging. The opioid receptor agonist D-Ala(2)-N-Me-Phe(4),Gly-ol(5)-enkephalin (DAMGO; 1 microM) dramatically increased the amplitude of spontaneous intracellular Ca(2+) oscillations in the hippocampal neurons, with synchronization of the Ca(2+) oscillations across neurons in a given field. The effects of DAMGO were blocked by the opioid receptor antagonist naloxone (1 microM) and were dependent on functional NMDA receptors and L-type Ca(2+) channels. In parallel whole-cell recordings, DAMGO enhanced spontaneous, synaptically driven NMDA receptor-mediated burst events, depolarizing responses to exogenous NMDA and current-evoked Ca(2+) spikes. These results show that the activation of opioid receptors can augment several components of neuronal Ca(2+) signaling pathways significantly and, as a consequence, enhance intracellular Ca(2+) signals. These results provide evidence of a novel neuronal mechanism of opioid action on CNS neuronal networks that may contribute to both short- and long-term effects of opioids.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • Animals
  • Calcium / metabolism*
  • Calcium Channels, L-Type / physiology*
  • Cells, Cultured
  • Embryo, Mammalian
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology*
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Hippocampus / physiology*
  • Kinetics
  • Membrane Potentials / drug effects
  • Naloxone / pharmacology
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / physiology*
  • Nimodipine / pharmacology
  • Oscillometry
  • Quinoxalines / pharmacology
  • Rats
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Receptors, Opioid / agonists
  • Tetrodotoxin / pharmacology
  • Time Factors

Substances

  • Calcium Channels, L-Type
  • Excitatory Amino Acid Antagonists
  • Quinoxalines
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Opioid
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Naloxone
  • Tetrodotoxin
  • Nimodipine
  • FG 9041
  • 2-Amino-5-phosphonovalerate
  • Calcium